CD274 and neoplasm: Additionally, patients identified as PD-L1–positive by AI-powered scoring alone demonstrated improved associations with survival compared with those identified as PD-L1–negative by both methods in some tumor types and clinical trials across different cutoffs (Supplementary Fig. 2).